PTC Therapeutics (PTCT) Stock Highlights

46.24 | +2.19%

2024-12-21 02:51:22

PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Statistics

Range Today

44.74 47.42

Volume Today 1.43M

Range 1 Year

23.58 54.16

Volume 1 Year 214.36M

Range 3 Year

17.53 59.84

Volume 3 Year 625.58M

Range 10 Year

4.03 78.72

Volume 10 Year 2.26B

Highlights

Market Capitalization 3.42B (mid)

Floating Shares 59.82M

Current Price 46.24

Price To Earnings -7.01

Price To Revenue 5.22

Earnings Per Share -6.51

Payout Ratio 0%

Performance

Latest +2.19%

1 Month +17.42%

3 Months +27.73%

6 Months +27.73%

1 Year +67.6%

3 Years +18.93%

5 Years -4.62%

10 Years -17.04%

Benchmarks

Market Capitalization

78 / 368

Gross Profits

114 / 278

Total Revenue

19 / 300

Total Rank

240 / 368

Free Cashflow

313 / 352

Performance 5 years

124 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.